Bromodomains: Translating the words of lysine acetylation into myelin injury and repair

Neuroscience Letters

Volumn 625, Issue , 2016, Pages 4-10

  Ntranos, Achilles ^a   Casaccia, Patrizia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Bromodomains; Lysine acetylation; Multiple sclerosis; Myelin injury; Remyelination

Indexed keywords

BROMODOMAIN INHIBITOR; CYTOKINE; HISTONE ACETYLTRANSFERASE PCAF; LYSINE; MYELIN; AUTACOID; HISTONE ACETYLTRANSFERASE;

BINDING AFFINITY; CELL DIFFERENTIATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DEREGULATION; ENZYME ACTIVITY; EPIGENETICS; HUMAN; IMMUNE SYSTEM; INFLAMMATION; MOLECULAR RECOGNITION; MULTIPLE SCLEROSIS; NEOPLASM; NERVE FIBER REGENERATION; NERVE INJURY; NONHUMAN; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ACETYLATION; ANIMAL; DEMYELINATING DISEASE; GENETIC EPIGENESIS; IMMUNOLOGY; METABOLISM; REGENERATION;

ACETYLATION; ANIMALS; CYTOKINES; DEMYELINATING DISEASES; EPIGENESIS, GENETIC; HISTONE ACETYLTRANSFERASES; HUMANS; INFLAMMATION MEDIATORS; LYSINE; PROTEIN PROCESSING, POST-TRANSLATIONAL; REGENERATION;

EID: 84949950539     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.10.015     Document Type: Review

References (40)

1. Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009, 325:834-840.
2. Filippakopoulos P., Knapp S. Targeting bromodomains: epigenetic readers of lysine acetylation. Nat. Rev. Drug Discov. 2014, 13:337-356.
3. Sanchez R., Zhou M.M. The role of human bromodomains in chromatin biology and gene transcription. Curr. Opin. Drug Discov. Dev. 2009, 12:659-665.
4. Pedre X., Mastronardi F., Bruck W., Lopez-Rodas G., Kuhlmann T., Casaccia P. Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions. J. Neurosci. 2011, 31:3435-3445.
5. Kuhlmann T., Miron V., Cui Q., Wegner C., Antel J., Bruck W. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 2008, 131:1749-1758.
6. Tamkun J.W., Deuring R., Scott M.P., Kissinger M., Pattatucci A.M., Kaufman T.C., et al. Brahma: a regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2. Cell 1992, 68:561-572.
7. Zeng L., Zhou M.M. Bromodomain an acetyl-lysine binding domain. FEBS Lett. 2002, 513:124-128.
8. Dhalluin C., Carlson J.E., Zeng L., He C., Aggarwal A.K., Zhou M.M. Structure and ligand of a histone acetyltransferase bromodomain. Nature 1999, 399:491-496.
9. Sanchez R., Pieper U., Melo F., Eswar N., Marti-Renom M.A., Madhusudhan M.S., et al. Protein structure modeling for structural genomics. Nat. Struct. Biol. 2000, (Suppl. 7):986-990.
10. Jeanmougin F., Wurtz J.M., Le Douarin B., Chambon P., Losson R. The bromodomain revisited. Trends Biochem. Sci. 1997, 22:151-153.
11. Li H., Ilin S., Wang W., Duncan E.M., Wysocka J., Allis C.D., et al. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature 2006, 442:91-95.
12. Zeng L., Yap K.L., Ivanov A.V., Wang X., Mujtaba S., Plotnikova O., et al. Structural insights into human KAP1 PHD finger-bromodomain and its role in gene silencing. Nat. Struct. Mol. Biol. 2008, 15:626-633.
13. Jacobson R.H., Ladurner A.G., King D.S., Tjian R. Structure and function of a human TAFII250 double bromodomain module. Science 2000, 288:1422-1425.
14. Muller S., Filippakopoulos P., Knapp S. Bromodomains as therapeutic targets. Expert Rev. Mol. Med. 2011, 13:e29.
15. Wu J.I., Lessard J., Crabtree G.R. Understanding the words of chromatin regulation. Cell 2009, 136:200-206.
16. Holmoy T. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets. Minerva Med. 2008, 99:119-140.
17. Windhagen A., Newcombe J., Dangond F., Strand C., Woodroofe M.N., Cuzner M.L., et al. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 1995, 182:1985-1996.
18. Bayarsaihan D. Epigenetic mechanisms in inflammation. J. Dent. Res. 2011, 90:9-17.
19. Barthel R., Tsytsykova A.V., Barczak A.K., Tsai E.Y., Dascher C.C., Brenner M.B., et al. Regulation of tumor necrosis factor alpha gene expression by mycobacteria involves the assembly of a unique enhanceosome dependent on the coactivator proteins CBP/p300. Mol. Cell Biol. 2003, 23:526-533.
20. Barnes P.J. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac Soc. 2009, 6:693-696.
21. Choi K.C., Lee Y.H., Jung M.G., Kwon S.H., Kim M.J., Jun W.J., et al. Gallic acid suppresses lipopolysaccharide-induced nuclear factor-kappaB signaling by preventing RelA acetylation in A549 lung cancer cells. Mol. Cancer Res. 2009, 7:2011-2021.
22. Hou T., Ray S., Lee C., Brasier A.R. The STAT3 NH2-terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain. J. Biol. Chem. 2008, 283:30725-30734.
23. Deng W.G., Zhu Y., Wu K.K. Role of p300 and PCAF in regulating cyclooxygenase-2 promoter activation by inflammatory mediators. Blood 2004, 103:2135-2142.
24. Huang B., Yang X.D., Zhou M.M., Ozato K., Chen L.F. Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol. Cell Biol. 2009, 29:1375-1387.
25. Khan Y.M., Kirkham P., Barnes P.J., Adcock I.M. Brd4 is essential for IL-1beta-induced inflammation in human airway epithelial cells. PLoS One 2014, 9:e95051.
26. Belkina A.C., Nikolajczyk B.S., Denis G.V. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. J. Immunol. 2013, 190:3670-3678.
27. Mele D.A., Salmeron A., Ghosh S., Huang H.R., Bryant B.M., Lora J.M. BET bromodomain inhibition suppresses TH17-mediated pathology. J. Exp. Med. 2013, 210:2181-2190.
28. Chikuma S., Suita N., Okazaki I.M., Shibayama S., Honjo T. TRIM28 prevents autoinflammatory T cell development in vivo. Nat. Immunol. 2012, 13:596-603.
29. Grade S., Bernardino L., Malva J.O. Oligodendrogenesis from neural stem cells: perspectives for remyelinating strategies. Int. J. Dev. Neurosci. 2013, 31:692-700.
30. Raine C.S., Wu E. Multiple sclerosis: remyelination in acute lesions. J. Neuropathol. Exp. Neurol. 1993, 52:199-204.
31. Prineas J.W., Barnard R.O., Kwon E.E., Sharer L.R., Cho E.S. Multiple sclerosis: remyelination of nascent lesions. Ann. Neurol. 1993, 33:137-151.
32. Gacias M., Gerona-Navarro G., Plotnikov A.N., Zhang G., Zeng L., Kaur J., et al. Selective chemical modulation of gene transcription favors oligodendrocyte lineage progression. Chem. Biol. 2014, 21:841-854.
33. Wang R., Liu W., Helfer C.M., Bradner J.E., Hornick J.L., Janicki S.M., et al. Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma. Cancer Res. 2014, 74:3332-3343.
34. Venkataraman S., Alimova I., Balakrishnan I., Harris P., Birks D.K., Griesinger A., et al. Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget 2014, 5:2355-2371.
35. Loven J., Hoke H.A., Lin C.Y., Lau A., Orlando D.A., Vakoc C.R., et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 2013, 153:320-334.
36. Magri L., Gacias M., Wu M., Swiss V.A., Janssen W.G., Casaccia P. c-Myc-dependent transcriptional regulation of cell cycle and nucleosomal histones during oligodendrocyte differentiation. Neuroscience 2014, 276:72-86.
37. Delmore J.E., Issa G.C., Lemieux M.E., Rahl P.B., Shi J., Jacobs H.M., et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 2011, 146:904-917.
38. Henssen A., Thor T., Odersky A., Heukamp L., El-Hindy N., Beckers A., et al. BET bromodomain protein inhibition is a therapeutic option for medulloblastoma. Oncotarget 2013, 4:2080-2095.
39. Gaub P., Joshi Y., Wuttke A., Naumann U., Schnichels S., Heiduschka P., et al. The histone acetyltransferase p300 promotes intrinsic axonal regeneration. Brain 2011, 134:2134-2148.
40. Lindner R., Puttagunta R., Di Giovanni S. Epigenetic regulation of axon outgrowth and regeneration in CNS injury: the first steps forward. Neurotherapeutics 2013, 10:771-781.